Mary Philip, M.D., Ph.D., is assistant professor of medicine in the Divisions of Hematology and Oncology and Pathology, Microbiology and Immunology at Vanderbilt. Her research is focused on unraveling T cell dysfunction in cancer and designing strategies to transform tumor-specific T cells into potent anti-cancer agents.
